376601-45-5

Upstream product

• 376601-44-4 (4-cyano-phenylamino)-(5-ethoxy-2-fluoro-3-hydroxy-phenyl)-acetic acid ethyl ester 
• 86087-23-2 (S)-3-hydroxytetyrahydrofurane 
• 1972-28-7 diethylazodicarboxylate 
• 873-74-5 4-Aminobenzonitrile 
• 459-26-7 4-ethoxy-1-fluorobenzene 
• 577793-68-1 3-(tert-butyl-dimethyl silanyloxy)-5-ethoxy-2-fluoro-benzaldehyde 
• 577793-67-0 tert-butyl-(5-ethoxy-2-fluoro-phenoxy)-dimethyl-silane 
• 577793-66-9 5-ethoxy-2-fluoro-phenol 

Relevant academic research and scientific papers

Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity

The discovery of a highly potent and selective tissue factor/factor VIIa inhibitor is described. Upon oral administration of its double prodrug in the guinea pig, a dose-dependent antithrombotic effect is observed in an established model of arterial throm

N-(4-carbamimidoyl-phenyl)-glycine derivatives

N-(4-carbamimidoyl-phenyl)-glycine derivatives have the formula: wherein X and R1 to R5 are as defined herein, and includes hydrates or solvates and/or physiologically acceptable salts thereof and/or physiologically acceptable esters